# Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance Imaging

> **NCT02090179** · — · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 5 (actual)

## Conditions studied

- MPS IIIB (Sanfilippo B Syndrome)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02090179
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2016-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02090179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02090179, "Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance Imaging". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02090179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*